BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35968895)

  • 1. Long-term Dependency in Older Adults After Surgery or Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Hirpara DH; Kidane B; Louie AV; Zuk V; Darling G; Rousseau M; Chesney T; Coburn N; Hallet J;
    Ann Surg; 2023 Aug; 278(2):e368-e376. PubMed ID: 35968895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer.
    Wolff HB; Alberts L; Kastelijn EA; Lissenberg-Witte BI; Twisk JW; Lagerwaard FJ; Senan S; El Sharouni SY; Schramel FMNH; Coupé VMH
    J Thorac Oncol; 2018 May; 13(5):689-698. PubMed ID: 29391288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
    Mayne NR; Lin BK; Darling AJ; Raman V; Patel DC; Liou DZ; D'Amico TA; Yang CJ
    Ann Surg; 2020 Dec; 272(6):925-929. PubMed ID: 33074904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin.
    Müller JA; Vordermark D; Medenwald D
    Strahlenther Onkol; 2023 Jul; 199(7):658-667. PubMed ID: 36912978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
    Ackerson BG; Tong BC; Hong JC; Gu L; Chino J; Trotter JW; D'Amico TA; Torok JA; Lafata K; Chang C; Kelsey CR
    Lung Cancer; 2018 Nov; 125():185-191. PubMed ID: 30429018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer.
    Wang Q; Stone K; Kern JA; Slatore CG; Swanson S; Blackstock W; Khan RS; Smith CB; Veluswamy RR; Chidel M; Wisnivesky JP
    Ann Am Thorac Soc; 2022 Dec; 19(12):2053-2061. PubMed ID: 35816617
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
    Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
    Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a-b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery.
    Henschke CI; Yip R; Sun Q; Li P; Kaufman A; Samstein R; Connery C; Kohman L; Lee P; Tannous H; Yankelevitz DF; Taioli E; Rosenzweig K; Flores RM; ;
    J Thorac Oncol; 2024 Mar; 19(3):476-490. PubMed ID: 37806384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.
    Khorfan R; Kruser TJ; Coughlin JM; Bharat A; Bilimoria KY; Odell DD
    Ann Thorac Surg; 2020 Jul; 110(1):228-234. PubMed ID: 32147416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.
    Yu JB; Soulos PR; Cramer LD; Decker RH; Kim AW; Gross CP
    Cancer; 2015 Jul; 121(14):2341-9. PubMed ID: 25847699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
    Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer.
    Razi SS; Kodia K; Alnajar A; Block MI; Tarrazzi F; Nguyen D; Villamizar N
    Ann Thorac Surg; 2021 May; 111(5):1659-1665. PubMed ID: 32891656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
    Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S; Taylor J; Sancheti M; Fernandez F; Moghanaki D
    Chest; 2022 Mar; 161(3):833-844. PubMed ID: 34785235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
    Varlotto J; Fakiris A; Flickinger J; Medford-Davis L; Liss A; Shelkey J; Belani C; DeLuca J; Recht A; Maheshwari N; Barriger R; Yao N; DeCamp M
    Cancer; 2013 Aug; 119(15):2683-91. PubMed ID: 23605504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Health-related Quality of Life among Individuals Considering Treatment for Stage I Non-Small-Cell Lung Cancer.
    Nugent SM; Golden SE; Hooker ER; Sullivan DR; Thomas CR; Deffebach ME; Sukumar MS; Schipper PH; Tieu BH; Moghanaki D; Wisnivesky J; Samson P; Robinson C; Slatore CG
    Ann Am Thorac Soc; 2020 Aug; 17(8):988-997. PubMed ID: 32433897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.